Cargando…

Progressive chorioretinal involvement in a patient with light-chain (AL) amyloidosis: a case report

BACKGROUND: To report an unusual case of light-chain (AL) amyloidosis with progressive bilateral chorioretinal abnormalities documented with short-wavelength autofluorescence, SD-OCT, fluorescein and indocyanine green angiography. CASE PRESENTATION: Case report of a forty-three-year-old male patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Augstburger, Edouard, Sahel, José-Alain, Audo, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035659/ https://www.ncbi.nlm.nih.gov/pubmed/32085748 http://dx.doi.org/10.1186/s12886-020-01341-z

Ejemplares similares

Light Chain (AL) Amyloidosis: The Journey to Diagnosis
por: McCausland, Kristen L., et al.
Publicado: (2017)

Cardiac involvement in light chain amyloidosis: a case report
por: Li, Jing, et al.
Publicado: (2020)

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
por: Palladini, Giovanni, et al.
Publicado: (2021)

Multiorgan involvement by amyloid light chain amyloidosis
por: Li, Guoliang, et al.
Publicado: (2019)

Light chain (AL) amyloidosis: update on diagnosis and management
por: Rosenzweig, Michael, et al.
Publicado: (2011)

Light Chain (AL) Cardiac Amyloidosis: A Diagnostic Dilemma
por: Abdelazeem, Basel, et al.
Publicado: (2021)

Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report
por: Draghici, Mirela, et al.
Publicado: (2021)

Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018)

Hepatic Involvement as the Sole Presentation of Systemic Amyloid Light Chain (AL) Amyloidosis: A Diagnostic Challenge
por: Kottavadakkeel, Nadeer, et al.
Publicado: (2023)

Racial disparities in patients diagnosed with light chain (AL) amyloidosis
por: D’Souza, Anita, et al.
Publicado: (2021)

Differences in Immunoglobulin Light Chain Species Found in Urinary Exosomes in Light Chain Amyloidosis (AL)
por: Ramirez-Alvarado, Marina, et al.
Publicado: (2012)

Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
por: Morgan, Gareth J., et al.
Publicado: (2021)

Cardiac involvement in heavy and light chain amyloidosis: A case report and literature review
por: Otaka, Yukihiro, et al.
Publicado: (2019)

Case for diagnosis. Systemic light chain amyloidosis with cutaneous involvement
por: Gontijo, João Renato Vianna, et al.
Publicado: (2017)

Systemic Immunoglobulin Light Chain Amyloidosis Involving the Large Intestine
por: Swaminathan, Renugadevi, et al.
Publicado: (2021)

Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium
por: Lousada, Isabelle, et al.
Publicado: (2015)

Immunoglobulin Light Chain (AL) Amyloidosis Preceding Marginal Zone Lymphoma: A Case Report
por: Doshi, Krishna, et al.
Publicado: (2022)

Jejunal Wall Thickening and Ulceration in a Patient With Amyloid Light-chain (AL) Amyloidosis
por: Drory, Samuel Bernard, et al.
Publicado: (2020)

PB1989: LIGHT CHAIN AMYLOIDOSIS (AL): THE EXPERIENCE OF A TUNISIAN CENTER
por: Kallel, F., et al.
Publicado: (2022)

Analysis of the complete lambda light chain germline usage in patients with AL amyloidosis and dominant heart or kidney involvement
por: Berghaus, Natalie, et al.
Publicado: (2022)

Lenalidomide Desensitization in Systemic Light-Chain Amyloidosis With Multi-Organ Involvement
por: Seki, Jack T., et al.
Publicado: (2015)

The clinical features and outcomes of systemic light chain amyloidosis with hepatic involvement
por: Zhao, Liang, et al.
Publicado: (2022)

A Rare Case of Didanosine-Induced Mid-Peripheral Chorioretinal Atrophy Identified Incidentally 11 Years after the Drug Cessation
por: Joharjy, Heba, et al.
Publicado: (2022)

Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis
por: Wechalekar, A D, et al.
Publicado: (2017)

Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) Amyloidosis
por: Jensen, Christopher E., et al.
Publicado: (2022)

Comparative Biochemical Outcomes, Effectiveness and Tolerance of Densiron 68 and Oxane HD for the Management of Complicated Retinal Detachment
por: Keilani, Chafik, et al.
Publicado: (2019)

Light-chain cardiac amyloidosis with neuropathy: a case report
por: Xu, Zhan-Wen, et al.
Publicado: (2015)

Systemic light chain amyloidosis myopathy responsive to daratumumab monotherapy
por: Chitimus, Diana Maria, et al.
Publicado: (2022)

Treatment patterns and outcomes in light chain amyloidosis: An institutional registry of amyloidosis report in Argentina
por: Posadas-Martinez, Maria Lourdes, et al.
Publicado: (2022)

Autopsy findings in a patient with primary systemic AL (kappa light chain) amyloidosis
por: Ledesma, Felipe Lourenço, et al.
Publicado: (2021)

Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis
por: Poshusta, Tanya L., et al.
Publicado: (2009)

Novel Therapies in Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017)

DUAL expectations in light chain amyloidosis
por: Schönland, Stefan, et al.
Publicado: (2020)

Light chain cardiac amyloidosis in a nonagenarian
por: Takahashi, Koji, et al.
Publicado: (2022)

Light chain lambda myeloma with fatal AL cardiac amyloidosis in a 21‐year‐old patient: A case report and review
por: Camus, Vincent, et al.
Publicado: (2019)

PB2151: CLINICAL FEATURES AND OUTCOMES OF DIFFUSE PULMONARY LIGHT CHAIN AMYLOIDOSIS: A RARE PRESENTATION OF SYSTEMIC AL AMYLOIDOSIS
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023)

Light chain Amyloidosis (AL) associated with multiple myeloma revealed by peripheral bilateral polyarthritis: a case report
por: Randrianarisoa, Rova Malala Fandresena, et al.
Publicado: (2021)

Splenic rupture secondary to amyloid light-chain (AL) amyloidosis associated with multiple myeloma
por: Buzalewski, Jarrod, et al.
Publicado: (2019)

Lingual liability: macroglossia and dyspnoea as the harbinger of systemic AL (light-chain) cardiac amyloidosis
por: Williams, Michael Uncle, et al.
Publicado: (2018)

Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease
por: Herrera, Guillermo A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iorp7gvbed9l2mpngcrjbkt0ku